Fusaro E, Maccario G, Orlando T, Ghione G L
Minerva Med. 1985 Nov 10;76(43):2047-52.
With absolutely no attempt to reject chemotherapy of lung cancer as useless, particularly now that extremely effective antiblastic products are available, it is however suggested that we should think carefully before adopting treatments of doubtful efficacy that may prolong the patient's life but also increase his suffering in that they produce extremely unpleasant side effects without having much influence on the basic symptoms. In such cases it may be the physician's painful duty to withhold treatment.
绝不是说要摒弃肺癌化疗，认为其毫无用处，尤其是现在已有极为有效的抗瘤产品。然而，有人建议，对于疗效存疑的治疗方法，我们应谨慎思考。这类治疗方法可能延长患者生命，但也会增加其痛苦，因为它们会产生极其难受的副作用，却对基本症状影响不大。在这种情况下，医生可能要忍痛停止治疗。
